-
深度参与2024国际生物医药产业创新论坛，CEO竺添就CGT的现在与未来阐述独到见解
2024年10月25-26日，引正基因（GenEditBio）CEO竺添博士受邀参加由北京经济技术开发区管理委员会及经开区协同医药医学创新促进中心（CMAC）协同主办的2024国际生物医药产业创新北京论坛。
넶0 2024-11-05 -
GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies
[Hong Kong, September 30th, 2024] – GenEditBio Limited (“GenEditBio”), a biotech company co-founded by Prof. ZHENG Zongli from the City University of Hong Kong that focuses on precision genome editing to provide affordable “precision DNA surgery” for genetic diseases with unmet needs, is pleased to have AEF Greater Bay Area Fund, managed by Gobi Partners GBA, a leading venture capital firm in Asia, invested in our company.
넶296 2024-09-30 -
Dr Zongli ZHENG Participated in Panel Discussion on Venture Fund Support to Start-ups at Asia Summit on Global Health 2024
[May 17, 2024] – GenEditBio Limited (“GenEditBio”), a biotech company focuses on precision genome editing to provide affordable “precision DNA surgery” for genetic diseases with unmet needs, is pleased to announce the participation of our Co-Founder and Chairman, Zongli ZHENG, PhD, as an invited guest speaker on a panel discussion on venture fund support to start-ups at the Asia Summit on Global Health (ASGH) on May 17, 2024, Hong Kong, China.
넶201 2024-05-17 -
GenEditBio to Present New Pre-Clinical Data for its Genome Editing and Delivery Platforms at the 27th Annual Meeting of the American Society of Gene and Cell Therapy
GenEditBio Limited (“GenEditBio”), a biotechnology start-up company focusing on genome-editing therapeutic solutions through the discovery of novel Cas nuclease and the development of safe and efficient cargo delivery platforms, today announced that the Company will have three poster presentations of pre-clinical data across platforms at the upcoming 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) to take place in Baltimore, Maryland, USA, May 8-11, 2024.
넶190 2024-04-30 -
引正基因完成新一轮融资，专注下一代基因编辑工具
2024年4月4日，基因编辑平台型技术企业引正基因科技有限公司（下称“引正基因”，GenEditBio）宣布完成千万美元的Pre-A+轮融资。
넶841 2024-04-04
